三个皮匠报告
最新
报告分类 研搜
BETA
政策库
自研报告
new
入驻
搜索
您的当前位置：首页 > 行业数据 > 表10辉瑞制药有潜力启动全球III期的SSGJ-707相关适应症
图片属性
图片格式：PNG 图片大小：247KB 图片尺寸：2443*1266
同报告图片
 / 4
表10辉瑞制药有潜力启动全球III期的SSGJ-707相关适应症_第1页
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
表10辉瑞制药有潜力启动全球III期的SSGJ-707相关适应症_第2页
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
表10辉瑞制药有潜力启动全球III期的SSGJ-707相关适应症_第3页
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
表10辉瑞制药有潜力启动全球III期的SSGJ-707相关适应症_第4页
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
表10辉瑞制药有潜力启动全球III期的SSGJ-707相关适应症_第5页
所属报告： 三生制药（1530.HK）-港股公司首次覆盖：主营业务稳健，迈向PD~1*VEGF的星辰大海-250730（30页）.pdf
打包全文图表

相关数据

最新数据
全行业研究报告分享下载平台
  • 0731-84720580
  • 商务合作：really158d
  • 友链申请 (QQ)：1737380874
关于我们
更多
关于我们
三个皮匠报告微信公众号
三个皮匠报告微信小程序
扫码咨询商务合作事宜
友情链接：
营销自动化 亿欧智库 微播易 阿里妈妈
copyright@2008-2013 长沙思想领动信息技术有限公司版权所有        网站备案/许可证号：湘B2-20190120 | 工信部备案号：湘ICP备2023027541号-2 | 公安备案号：湘公网安备43010402001071号
客服
商务合作
小程序
服务号
折叠